ReviewHematology. American Society of Hematology. Education Program2016

The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors.

Fabio Efficace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.